Drug Name Levaquin

Unwanted effects. Hypoglycemia results from absolute or relative overdosage. Allergic reactions are rare—locally: redness at injection site, atrophy of adipose tissue (lipodystrophy); systemically: urticaria, skin rash, anaphylaxis. Insulin resistance can result from binding to inactivating antibodies. A possible local lipohypertrophy can be avoided by alternating injection sites.
Muscle relaxants cause a flaccid paralysis of skeletal musculature by binding to motor endplate cholinoceptors, thus blocking neuromuscular transmission (p. 182). According to whether receptor occupancy leads to a blockade or an excitation of the endplate, one distinguishes nondepolarizing from depolarizing muscle relaxants.

 

The primary consequence of activation is a conformational change of an integrin present in the platelet membrane, namely, GPIIB/IIIA. In its active conformation, GPIIB/IIIA shows high affinity for fibrinogen; each platelet contains up to 50,000 copies.
It is a protein (MW 5800) consisting of two peptide chains linked by two disulfide bridges; the A chain has 21 and the B chain 30 amino acids. Insulin is the “blood-sugar lowering” hormone.